Emil Kuriakose Terns Pharmaceuticals, Inc. (TERN) insider trading activity

Emil Kuriakose is Chief Medical Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 106,615 shares of TERN, which is worth approximately $2.4 Million. The most recent transaction as insider was on Jan 14, 2026, when has been sold 56,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

106.94% 3M change

96.46% 12M change

Total Value Held $2.4 Million

Emil Kuriakose Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 14 2026	BUY Grant, award, or other acquisition	-	56,250 Added 34.54%	106,615 Common Stock
Jan 02 2026	SELL Open market or private sale	$45,021 $38.98 p/Share	1,155 Reduced 2.24%	50,365 Common Stock
Oct 01 2025	SELL Open market or private sale	$7,410 $7.85 p/Share	944 Reduced 1.8%	51,520 Common Stock
Jul 01 2025	SELL Open market or private sale	$3,642 $4.27 p/Share	853 Reduced 1.6%	52,464 Common Stock
Apr 01 2025	SELL Open market or private sale	$2,370 $2.49 p/Share	952 Reduced 1.75%	53,317 Common Stock
Jan 02 2025	SELL Open market or private sale	$25,586 $5.71 p/Share	4,481 Reduced 7.63%	54,269 Common Stock

Also insider at

CALA

Calithera Biosciences, Inc. Healthcare

CHIEF MEDICAL OFFICER

Emil Kuriakose

Chief Medical Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Value

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Terns Pharmaceuticals, Inc.

Track Activities on TERN

Account